EXHIBIT 99.2




                   K-V PHARMACEUTICAL COMPANY AND SUBSIDIARIES


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of K-V Pharmaceutical Company (the
"Company") on Form 10-Q for the period ending June 30, 2002 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Gerald
R. Mitchell, Vice President, Treasurer and Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

        (3)  The Report fully complies with the requirements of section 13(a)
             or 15(d) of the Securities Exchange Act of 1934; and

        (4)  The information contained in the Report fairly presents, in all
             material respects, the financial condition and result of
             operations of the Company.


/s/  GERALD R. MITCHELL
-----------------------------------------------------
Gerald R. Mitchell
Vice President, Treasurer and Chief Financial Officer
August 9, 2002